Journal:Protein Science:2

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (10:34, 12 December 2024) (edit) (undo)
 
(6 intermediate revisions not shown.)
Line 1: Line 1:
-
<StructureSection load='' size='450' side='right' scene='72/725874/Cv/26' caption=''>
+
<StructureSection load='' size='450' side='right' scene='72/725874/Cv/39' caption=''>
===The Impact of Crystallization Conditions on Structure-Based Drug Design: a Case Study on the Methylene Blue/Acetylcholinesterase Complex===
===The Impact of Crystallization Conditions on Structure-Based Drug Design: a Case Study on the Methylene Blue/Acetylcholinesterase Complex===
-
<big>Orly Dym, Wanling Song, Clifford Felder, Esther Roth, Valery Shnyrov, Yacov, Ashani, Yechun Xu, Robbie P. Joosten, Lev Weiner, Joel L. Sussman, and Israel Silman</big> <ref>REF</ref>
+
<big>Orly Dym, Wanling Song, Clifford Felder, Esther Roth, Valery Shnyrov, Yacov, Ashani, Yechun Xu, Robbie P. Joosten, Lev Weiner, Joel L. Sussman, and Israel Silman</big> <ref>PMID:26990888</ref>
<hr/>
<hr/>
<b>Molecular Tour</b><br>
<b>Molecular Tour</b><br>
-
Crystal structure of ''Tc''AChE <scene name='72/725874/Cv/27'>shows its two subdomains</scene> (<font color='purple'><b>residues 4-305, purple</b></font>, and <font color='red'><b>residues 306-535, red</b></font>). The <scene name='72/725874/Cv/29'>entrance to the active-site gorge</scene> located between the two sub-domains. There are several of the conserved aromatic residues: <scene name='72/725874/Cv/30'>Trp279</scene>, in the peripheral anionic site (PAS) at the top of the gorge; <scene name='72/725874/Cv/31'>Tyr121</scene>, mid-way down the gorge, and <scene name='72/725874/Cv/7'>Trp84</scene>, the principal element of the catalytic ‘anionic’ sub-site (CAS), near the bottom. CAS involves the <scene name='72/725874/Cv/9'>catalytic triad Ser200, His440, and Glu327</scene>. <span style="color:yellow;background-color:black;font-weight:bold;">The carbon atoms of these conserved residues colored yellow</span>.
+
Crystal structure of ''Tc''AChE <scene name='72/725874/Cv/40'>shows its two subdomains</scene> (<font color='purple'><b>residues 4-305, purple</b></font>, and <font color='red'><b>residues 306-535, red</b></font>). The <scene name='72/725874/Cv/29'>entrance to the active-site gorge</scene> located between the two sub-domains. There are several of the conserved aromatic residues: <scene name='72/725874/Cv/30'>Trp279</scene>, in the peripheral anionic site (PAS) at the top of the gorge; <scene name='72/725874/Cv/31'>Tyr121</scene>, mid-way down the gorge, and <scene name='72/725874/Cv/32'>Trp84</scene>, the principal element of the catalytic ‘anionic’ sub-site (CAS), near the bottom. CAS involves the <scene name='72/725874/Cv/33'>catalytic triad Ser200, His440, and Glu327</scene>. <span style="color:yellow;background-color:black;font-weight:bold;">The carbon atoms of these conserved residues colored yellow</span>.
Structure-based drug design utilizes experimental 3D apo-protein or complex structures that are usually retrieved from the PDB. Over 57% of the crystallographic PDB entries were obtained with polyethyleneglycols (PEGs) as precipitant and/or as cryoprotectant, but fewer than 6% of
Structure-based drug design utilizes experimental 3D apo-protein or complex structures that are usually retrieved from the PDB. Over 57% of the crystallographic PDB entries were obtained with polyethyleneglycols (PEGs) as precipitant and/or as cryoprotectant, but fewer than 6% of
these report the presence of individual PEGs. We here report a case in which presence of PEG in a crystal structure markedly affected the bound ligand’s position. Specifically, we compared the positions of methylene blue and of decamethonium in the acetylcholinesterase complexes obtained using isomorphous crystals precipitated with PEG200 or ammonium sulfate. The ligands’ positions within the active-site gorge in complexes obtained using PEG200 as precipitant are influenced by the presence of ethyleneglycol oligomers. In both cases, an ethyleneglycol dimer is bound to W84 at the gorge’s bottom, preventing their proximal quaternary groups’ interaction with its indole. Consequently, both ligands are ~2.5 Å further up the gorge than in complexes obtained using crystals precipitated with ammonium sulfate, in which these quaternary groups make a direct π-cation interaction with the indole. These findings have implications for structure-based drug design, since data for ligand-protein complexes with PEG as precipitant may not reflect the ligand’s position in its absence, and could result in selection of incorrect lead compounds for drug discovery. Docking methylene blue into the protein structure of the complex obtained with PEG200, but omitting the ethyleneglycol dimer yields results in poor agreement with the crystal structure; excellent agreement is obtained if the ethyleneglycol dimer is included. Many proteins display structural elements in which precipitants like PEG might lodge. It will be important to investigate presence of precipitants in published crystal structures, and whether it has resulted in misinterpretation of electron density maps, thus adversely affecting drug design.
these report the presence of individual PEGs. We here report a case in which presence of PEG in a crystal structure markedly affected the bound ligand’s position. Specifically, we compared the positions of methylene blue and of decamethonium in the acetylcholinesterase complexes obtained using isomorphous crystals precipitated with PEG200 or ammonium sulfate. The ligands’ positions within the active-site gorge in complexes obtained using PEG200 as precipitant are influenced by the presence of ethyleneglycol oligomers. In both cases, an ethyleneglycol dimer is bound to W84 at the gorge’s bottom, preventing their proximal quaternary groups’ interaction with its indole. Consequently, both ligands are ~2.5 Å further up the gorge than in complexes obtained using crystals precipitated with ammonium sulfate, in which these quaternary groups make a direct π-cation interaction with the indole. These findings have implications for structure-based drug design, since data for ligand-protein complexes with PEG as precipitant may not reflect the ligand’s position in its absence, and could result in selection of incorrect lead compounds for drug discovery. Docking methylene blue into the protein structure of the complex obtained with PEG200, but omitting the ethyleneglycol dimer yields results in poor agreement with the crystal structure; excellent agreement is obtained if the ethyleneglycol dimer is included. Many proteins display structural elements in which precipitants like PEG might lodge. It will be important to investigate presence of precipitants in published crystal structures, and whether it has resulted in misinterpretation of electron density maps, thus adversely affecting drug design.
-
In certain crystal structures of complexes for which the native crystals have been generated using PEG as the precipitant, PEG oligomers can be seen within the gorge. For example, in the galanthamine/''Tc''AChE complex ([[1dx6]]), a <scene name='72/725874/Cv1/3'>PEG tetramer can be seen stacked above the galanthamine at the top of the gorge</scene>. The <span style="color:lime;background-color:black;font-weight:bold;">galanthamine is shown in space-filling format in green</span>, and above it a <font color='magenta'><b>PEG tetramer in magenta</b></font>.
+
In certain crystal structures of complexes for which the native crystals have been generated using PEG as the precipitant, PEG oligomers can be seen within the gorge. For example, in the galanthamine/''Tc''AChE complex ([[1dx6]]), a <scene name='72/725874/Cv1/18'>PEG tetramer can be seen stacked above the galanthamine at the top of the gorge</scene>. The <span style="color:lime;background-color:black;font-weight:bold;">galanthamine is shown in space-filling format in green</span>, and above it a <font color='magenta'><b>PEG tetramer in magenta</b></font>.
-
The DECA molecule in the DECA-AS/''Tc''AChE structure ([[5e4j]]) is aligned along the axis of the active-site gorge, spanning the CAS and the PAS. The DECA makes non-bonded interactions with six of the conserved aromatic residues that line the gorge surface, ''viz.'', <scene name='72/725874/Cv/20'>Tyr70, Trp84, Tyr121, Trp279, Phe330 and Phe331</scene>.
+
The DECA molecule in the DECA-AS/''Tc''AChE structure ([[5e4j]]) is aligned along the axis of the active-site gorge, spanning the CAS and the PAS. The DECA makes non-bonded interactions with six of the conserved aromatic residues that line the gorge surface, ''viz.'', <scene name='72/725874/Cv/34'>Tyr70, Trp84, Tyr121, Trp279, Phe330 and Phe331</scene>.
-
In the DECA-PEG/''Tc''AChE structure ([[5e2i]]) a <scene name='72/725874/Cv/21'>PEG oligomer is seen at the bottom of the active-site gorge</scene>, between the proximal quaternary group of the DECA and the indole ring of Trp84. <font color='red'><b>DECA molecule is colored red</b></font>, and the <font color='blue'><b>PEG moiety blue</b></font>. Due to the presence of the PEG molecule oligomer at the bottom of the gorge in the DECA-PEG/TcAChE structure, the DECA molecule is positioned further up the gorge than in the DECA-AS/''Tc''AChE structure. <scene name='72/725874/Cv/25'>Overlay of the DECA-PEG/TcAChE and DECA-AS/TcAChE structures</scene>. The <font color='red'><b>DECA in the DECA-PEG/''Tc''AChE structure is shown as red ball-and-sticks</b></font>, and the <font color='blue'><b>PEG oligomers as blue ball-and-sticks</b></font>. The <span style="color:cyan;background-color:black;font-weight:bold;">DECA in the DECA-AS/''Tc''AChE structure is shown as cyan ball-and-sticks</span>. <scene name='72/725874/Cv/24'>Click here to see animation of this scene</scene>.
+
In the DECA-PEG/''Tc''AChE structure ([[5e2i]]) a <scene name='72/725874/Cv/35'>PEG oligomer is seen at the bottom of the active-site gorge</scene>, between the proximal quaternary group of the DECA and the indole ring of Trp84. <font color='red'><b>DECA molecule is colored red</b></font>, and the <font color='blue'><b>PEG moiety blue</b></font>. Due to the presence of the PEG molecule oligomer at the bottom of the gorge in the DECA-PEG/TcAChE structure, the DECA molecule is positioned further up the gorge than in the DECA-AS/''Tc''AChE structure. <scene name='72/725874/Cv/38'>Overlay of the DECA-PEG/TcAChE and DECA-AS/TcAChE structures</scene>. The <font color='red'><b>DECA in the DECA-PEG/''Tc''AChE structure is shown as red ball-and-sticks</b></font>, and the <font color='blue'><b>PEG oligomers as blue ball-and-sticks</b></font>. The <span style="color:cyan;background-color:black;font-weight:bold;">DECA in the DECA-AS/''Tc''AChE structure is shown as cyan ball-and-sticks</span>. <scene name='72/725874/Cv/37'>Click here to see animation of this scene</scene>.
<scene name='72/725874/Cv1/10'>MB within the gorge of the MB-AS/TcAChE complex</scene> ([[5dlp]]). <font color='purple'><b>The MB molecule is colored purple</b></font>. In MB-PEG/''Tc''AChE complex ([[5e4t]]) <scene name='72/725874/Cv1/8'>one PGE nests against MB at the top of the active-site gorge, a PEG is midway down the gorge, and one an additional PGE is located at the bottom of the gorge, between the proximal dimethylamino moiety of MB and the indole ring of Trp84</scene>. Consequently, the MB molecule is positioned further up the gorge than in the MB-AS/''Tc''AChE complex. <scene name='72/725874/Cv1/14'>Overlay of the MB-PEG/TcAChE and MB-AS/TcAChE structures</scene>. <font color='purple'><b>The MB in the MB-PEG/''Tc''AChE structure is shown as purple ball-and-sticks</b></font>, and the <font color='blue'><b>PEG/PGE oligomers as blue ball-and-sticks</b></font>. The <span style="color:deeppink;background-color:black;font-weight:bold;">MB in the MB-AS/''Tc''AChE structure is shown as pink ball-and-sticks</span>. <scene name='72/725874/Cv1/15'>Click here to see animation of this scene</scene>.
<scene name='72/725874/Cv1/10'>MB within the gorge of the MB-AS/TcAChE complex</scene> ([[5dlp]]). <font color='purple'><b>The MB molecule is colored purple</b></font>. In MB-PEG/''Tc''AChE complex ([[5e4t]]) <scene name='72/725874/Cv1/8'>one PGE nests against MB at the top of the active-site gorge, a PEG is midway down the gorge, and one an additional PGE is located at the bottom of the gorge, between the proximal dimethylamino moiety of MB and the indole ring of Trp84</scene>. Consequently, the MB molecule is positioned further up the gorge than in the MB-AS/''Tc''AChE complex. <scene name='72/725874/Cv1/14'>Overlay of the MB-PEG/TcAChE and MB-AS/TcAChE structures</scene>. <font color='purple'><b>The MB in the MB-PEG/''Tc''AChE structure is shown as purple ball-and-sticks</b></font>, and the <font color='blue'><b>PEG/PGE oligomers as blue ball-and-sticks</b></font>. The <span style="color:deeppink;background-color:black;font-weight:bold;">MB in the MB-AS/''Tc''AChE structure is shown as pink ball-and-sticks</span>. <scene name='72/725874/Cv1/15'>Click here to see animation of this scene</scene>.

Current revision

Drag the structure with the mouse to rotate
  1. Dym O, Song W, Felder C, Roth E, Shnyrov V, Ashani Y, Xu Y, Joosten RP, Weiner L, Sussman JL, Silman I. The Impact of Crystallization Conditions on Structure-Based Drug Design: A Case Study on the Methylene Blue/Acetylcholinesterase Complex. Protein Sci. 2016 Mar 14. doi: 10.1002/pro.2923. PMID:26990888 doi:http://dx.doi.org/10.1002/pro.2923

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Joel L. Sussman, Jaime Prilusky

This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
Personal tools